<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02641405</url>
  </required_header>
  <id_info>
    <org_study_id>CE/PROG.478</org_study_id>
    <nct_id>NCT02641405</nct_id>
  </id_info>
  <brief_title>Efficacy of Proprioceptive Focal Stimulation (EQUISTASI) on Gait Parameters in Parkinson. Italian Multicentric Study</brief_title>
  <acronym>PAGE</acronym>
  <official_title>Efficacy of Proprioceptive Focal Stimulation (EQUISTASI) on Gait Parameters in Parkinson. Italian Multicentric Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>I.R.C.C.S. Fondazione Santa Lucia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Istituto Auxologico Italiano</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IRCCS National Neurological Institute &quot;C. Mondino&quot; Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale S. Raffaele Arcangelo, Fatebenefratelli</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Genova</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>I.R.C.C.S. Fondazione Santa Lucia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It's already known the efficacy of Gait Analysis (GA) on evaluating gait modification on
      Parkinson's Disease (PD) Patients (1). On the other hand Proprioceptive Focal Stimulation
      seems be useful in symptoms amelioration in several neurological disease. Few studies have
      been performed in Parkinson's disease. A total of 126 patients suffering from PD will be
      recruited in 6 italian neurological centers. The study will be a cross-over multicenter study
      with the randomization of the sequence. The patients will be randomly assigned to 2 groups
      receiving for 8 weeks either the Equistasi medical device, or an equivalent placebo. Gait
      analysis will be recorded in each patient at the beginning and at the end of the treatment
      assigned. After 4 weeks of wash-out, the treatment will be crossed and a new gait analysis
      recording will be performed. Finally a last recording will be taken at the end of the last 8
      weeks. Secondary outcome will be the MDS-UPDRS (Movement Disorder Society - Unified Parkinson
      Disease Rating Scale), PDQ-39 (Parkinson Disease 39 Questionnaire ), ABC (Activity Specific
      Balance Confidence Scale).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in Spatio-Temporal gait variables at 20 weeks</measure>
    <time_frame>20 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in the Movement Disorder Society - Unified Parkinson Disease Rating Scale (MDS-UPDRS) - at 20 weeks</measure>
    <time_frame>20 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the Parkinson Disease 39 Questionnaire (PDQ-39) at 20 weeks</measure>
    <time_frame>20 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the Activity Specific Balance Confidence Scale (ABC scale) at 20 weeks</measure>
    <time_frame>20 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Parkinson Disease</condition>
  <condition>Gait, Shuffling</condition>
  <condition>Effects of Vibration</condition>
  <arm_group>
    <arm_group_label>Equistasi</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Equistasi is a nanotechnology for proprioceptive focal stimulation. Every patient will receive three patches to be placed at C7 and at the gastrocnemial junction of both legs.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Inactive Equistasi will be given to every patient in the form of three patches to be placed at C7 and at the gastrocnemial junction of both legs.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Equistasi</intervention_name>
    <description>Equistasi is a nanotechnology for proprioceptive focal stimulation. Every patient will receive three patches to be placed at C7 and at the gastrocnemial junction of both legs.</description>
    <arm_group_label>Equistasi</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Inactive Equistasi</intervention_name>
    <description>Inactive Equistasi will be given to every patient in the form of three patches to be placed at C7 and at the gastrocnemial junction of both legs.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with rigid-acinetic bilateral PD form

          -  At least 4 years of disease history

          -  H&amp;Y between 2-3

          -  Stable drug therapy response without any change performed in the 3 months before the
             study.

          -  Presence of freezing (FOG) and of postural instability not responding to parkinsonian
             therapy.

          -  MMSE&gt;24/30 (Mini-Mental State Examination)

        Exclusion Criteria:

          -  Systemic illness

          -  Presence of cardiac pacemaker

          -  Presence of deep brain stimulation

          -  Presence of severe dysautonomia with marked hypotension

          -  Obsessive-Compulsive disorder (OCD)

          -  Major depression

          -  Dementia

          -  History or active neoplasia

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>IRCCS Santa Lucia</name>
      <address>
        <city>Rome</city>
        <state>Lazio</state>
        <zip>00179</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>IRCCS National Neurological Institute &quot;C. Mondino&quot; Foundation</name>
      <address>
        <city>Pavia</city>
        <state>PV</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giorgio Sandrini, MD, PROF</last_name>
      <email>giorgio.sandrini@unipv.it</email>
    </contact>
    <investigator>
      <last_name>Giorgio Sandrini, MD, PROF</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Micol Avenali, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Auxologico Italiano</name>
      <address>
        <city>Oggebbio</city>
        <state>Verbano-Cusio-Ossola</state>
        <zip>28824</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Albani, MD</last_name>
      <email>g.albani@auxologico.it</email>
    </contact>
    <investigator>
      <last_name>Giovanni Albani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS San Raffaele</name>
      <address>
        <city>Cassino</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Francesca De Pandis, MD</last_name>
      <email>maria.depandis@hsanraffaele.it</email>
    </contact>
    <investigator>
      <last_name>Maria Francesca De Pandis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Genova</name>
      <address>
        <city>Genova</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giovanni Abbruzzese, MD,PROF</last_name>
      <email>gabbar@unigev.it</email>
    </contact>
    <investigator>
      <last_name>Giovanni Abruzzese, MD,PROF</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elisa Pelosin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Raffaele Arcangelo, Fatebenefratelli</name>
      <address>
        <city>Venezia</city>
        <zip>30121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniele Volpe, MD</last_name>
      <email>dott.dvolpe@libero.it</email>
    </contact>
    <investigator>
      <last_name>Daniele Volpe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 3, 2015</study_first_submitted>
  <study_first_submitted_qc>December 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2015</study_first_posted>
  <last_update_submitted>August 18, 2017</last_update_submitted>
  <last_update_submitted_qc>August 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>I.R.C.C.S. Fondazione Santa Lucia</investigator_affiliation>
    <investigator_full_name>Antonella Peppe</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Gait analysis</keyword>
  <keyword>Proprioceptive focal stimulation</keyword>
  <keyword>Parkinson</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Gait Disorders, Neurologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

